GroPep accepts friendly bid

Published: 7-Dec-2006
Media

Shareholders at Australian company GroPep have voted overwhelmingly to accept a friendly A$96m takeover bid from Danish company Novozymes, which offered to pay shareholders A$2.05/share.


Shareholders at Australian company GroPep have voted overwhelmingly to accept a friendly A$96m takeover bid from Danish company Novozymes, which offered to pay shareholders A$2.05/share.

Less than 0.3% per cent of the options on issue voted against.

Novozymes's takeover bid was launched in August and endorsed by an independent expert's report which valued GroPep shares between A$1.79 and A$2.09 each.

  • Companies:
  • Novozymes
See more

You may also like

Media

Novozymes strengthens position in India

Read more
Danish company Novozymes has today signed a definitive agreement to acquire the enzyme activities of Biocon, based in Bangalore, India, for the equivalent of DKK511m (US$115m).

Trending Articles

  1. Optimising excipients to improve bioavailability Guy Tiene, Director of Strategic Content, That's Nice LLC/Nice Insight, discusses excipient market trends, the use of excipients to improve the poor aqueous solubility of increasingly complex drug candidates and how drug developers choose excipient suppliers
  2. GEA Pharma & Healthcare share company updates at CPHI Barcelona Jim Holman, Technology Management Senior Director at GEA Pharma & Healthcare, discusses the company's recent endeavours to enhance the sustainability of their manufacturing procedures, the development of their novel tablet press range and the digital Canary system
  3. At Pharmintech 2022 the future of life sciences industries Contents and events of the special edition 'powered by Ipack Ima' presented in Milan
  4. Lactalis eyes Aspen's infant formula division The French dairy product manufacturer would boost its potential in the Chinese market if deal is successful
  5. Amazon poised to make huge strides in healthcare Globaldata has predicted that the American electronic commerce and cloud computing company is set to make significant gains in connecting consumers to healthcare

Upcoming event

Lab Innovations

30-31 October 2024 | Exhibition | Birmingham, UK See all

You may also like

Media

Novozymes strengthens position in India

<p>Danish company Novozymes has today signed a definitive agreement to acquire the enzyme activities of Biocon, based in Bangalore, India, for the equivalent of DKK511m (US$115m). </p>
Media

BioPharma Dynamics proudly sponsor GMCC Excellence Awards

BioPharma Dynamics is proud to continue their headline sponsorship of Greater Manchester Chamber of Commerce Excellence Awards, championing success and achievements of businesses within the Greater Manchester region
Media

Chemspec Europe 2024 conference programme unveiled

A detailed look at key speakers, sessions, and networking opportunities at the international exhibition
Media

Curia receives 2024 CDMO leadership award

Curia recognised for its service in the CDMO industry
Media

Biovian and 3P Biopharmaceuticals join forces to create 3PBIOVIAN

Biovian and 3P Biopharmaceuticals, two leading biologics CDMOs, announce their combination to establish a new pan-European leader in their field
Media

Royal Society of Chemistry and TIB co-create next generation Open Access consortium model

The agreement delivers shared goals of equity for institutions, a community approach and universal open access for authors
Media

Thermo Fisher launches industry’s first off-the-shelf solution to streamline and automate cell therapy manufacturing

Gibco CTS Cellmation Software digitally connects instruments from across Thermo Fisher’s cell therapy portfolio to streamline and automate manufacturing
Subscribe now